Clinical trial
Effects of Atomoxetine on Cognitive Function in Schizophrenia
NCT00420498 is registered in ClinicalTrials.gov with Yale University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Atomoxetine on Cognitive Function in Schizophrenia
- Lead sponsor
- Yale University
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- August 31, 2005
- Completion date
- September 30, 2007
- Enrollment
- 12 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cognition, schizophrenia, smoking